반응식
[NH2:1][C:2]1[C:3]([C:20]([NH:22][NH2:23])=[O:21])=[N:4][C:5]([C:8]2[CH:13]=[CH:12][C:11]([S:14]([CH:17]([CH3:19])[CH3:18])(=[O:16])=[O:15])=[CH:10][CH:9]=2)=[CH:6][N:7]=1.[C:24]([N:27]=[C:28]=[S:29])(=[O:26])[CH3:25]>ClCCCl>[NH2:1][C:2]1[C:3]([C:20]([NH:22][NH:23][C:28]([NH:27][C:24](=[O:26])[CH3:25])=[S:29])=[O:21])=[N:4][C:5]([C:8]2[CH:9]=[CH:10][C:11]([S:14]([CH:17]([CH3:19])[CH3:18])(=[O:15])=[O:16])=[CH:12][CH:13]=2)=[CH:6][N:7]=1참가 물질
4
실험 절차
A mixture of 3-amino-6-(4-isopropylsulfonylphenyl)pyrazine-2-carbohydrazide (100 mg, 0.2982 mmol), acetyl isothiocyanate (30.16 mg, 26.20 μL, 0.2982 mmol) and dry DCE (2.000 mL) were stirred at ambient temperature for 2 h and then concentrated in vacuo. Used directly in the next step without further purification; MS (ES+) 437.20
후처리
- concentrationconcentrated in vacuo
- customUsed directly in the next step without further purification
출처 및 근거
- ORD 기록
- ord-043d034c9784469faaa1a138f7c89591
- 출처 데이터셋
- uspto-grants-2016_06
- 특허 번호
- US09365557B2
연결된 노트
불러오는 중…